238 related articles for article (PubMed ID: 22385316)
1. Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission.
Friend DR
Expert Opin Drug Deliv; 2012 Apr; 9(4):417-27. PubMed ID: 22385316
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring.
Moss JA; Malone AM; Smith TJ; Kennedy S; Kopin E; Nguyen C; Gilman J; Butkyavichene I; Vincent KL; Motamedi M; Friend DR; Clark MR; Baum MM
Antimicrob Agents Chemother; 2012 Feb; 56(2):875-82. PubMed ID: 22123689
[TBL] [Abstract][Full Text] [Related]
3. Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologies.
Friend DR; Doncel GF
Antiviral Res; 2010 Dec; 88 Suppl 1():S47-54. PubMed ID: 21109068
[TBL] [Abstract][Full Text] [Related]
4. Multipurpose prevention technologies: products in development.
Friend DR; Clark JT; Kiser PF; Clark MR
Antiviral Res; 2013 Dec; 100 Suppl():S39-47. PubMed ID: 24188708
[TBL] [Abstract][Full Text] [Related]
5. An update on multipurpose prevention technologies for the prevention of HIV transmission and pregnancy.
Friend DR
Expert Opin Drug Deliv; 2016; 13(4):533-45. PubMed ID: 26742698
[TBL] [Abstract][Full Text] [Related]
6. Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model.
Smith JM; Moss JA; Srinivasan P; Butkyavichene I; Gunawardana M; Fanter R; Miller CS; Sanchez D; Yang F; Ellis S; Zhang J; Marzinke MA; Hendrix CW; Kapoor A; Baum MM
PLoS One; 2017; 12(10):e0185946. PubMed ID: 28982161
[TBL] [Abstract][Full Text] [Related]
7. A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy.
Ugaonkar SR; Wesenberg A; Wilk J; Seidor S; Mizenina O; Kizima L; Rodriguez A; Zhang S; Levendosky K; Kenney J; Aravantinou M; Derby N; Grasperge B; Gettie A; Blanchard J; Kumar N; Roberts K; Robbiani M; Fernández-Romero JA; Zydowsky TM
J Control Release; 2015 Sep; 213():57-68. PubMed ID: 26091920
[TBL] [Abstract][Full Text] [Related]
8. Multipurpose prevention technologies: biomedical tools to prevent HIV-1, HSV-2, and unintended pregnancies.
Thurman AR; Clark MR; Doncel GF
Infect Dis Obstet Gynecol; 2011; 2011():1-10. PubMed ID: 21836811
[TBL] [Abstract][Full Text] [Related]
9. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection.
Shankar GN; Alt C
J Antimicrob Chemother; 2014 Dec; 69(12):3282-93. PubMed ID: 25139839
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety.
Wilson SS; Cheshenko N; Fakioglu E; Mesquita PM; Keller MJ; Herold BC
Antivir Ther; 2009; 14(8):1113-24. PubMed ID: 20032541
[TBL] [Abstract][Full Text] [Related]
12. Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication.
Andrei G; Lisco A; Vanpouille C; Introini A; Balestra E; van den Oord J; Cihlar T; Perno CF; Snoeck R; Margolis L; Balzarini J
Cell Host Microbe; 2011 Oct; 10(4):379-89. PubMed ID: 22018238
[TBL] [Abstract][Full Text] [Related]
13. Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection.
Mesquita PM; Rastogi R; Segarra TJ; Teller RS; Torres NM; Huber AM; Kiser PF; Herold BC
J Antimicrob Chemother; 2012 Jul; 67(7):1730-8. PubMed ID: 22467632
[TBL] [Abstract][Full Text] [Related]
14. Multipurpose prevention technologies for sexual and reproductive health: mapping global needs for introduction of new preventive products.
Schelar E; Polis CB; Essam T; Looker KJ; Bruni L; Chrisman CJ; Manning J
Contraception; 2016 Jan; 93(1):32-43. PubMed ID: 26385588
[TBL] [Abstract][Full Text] [Related]
15. Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections.
Friend DR
Drug Deliv Transl Res; 2011 Jun; 1(3):185-93. PubMed ID: 25788239
[TBL] [Abstract][Full Text] [Related]
16. Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges.
Smith JM; Rastogi R; Teller RS; Srinivasan P; Mesquita PM; Nagaraja U; McNicholl JM; Hendry RM; Dinh CT; Martin A; Herold BC; Kiser PF
Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16145-50. PubMed ID: 24043812
[TBL] [Abstract][Full Text] [Related]
17. Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection.
Abdool Karim SS; Abdool Karim Q; Kharsany AB; Baxter C; Grobler AC; Werner L; Kashuba A; Mansoor LE; Samsunder N; Mindel A; Gengiah TN;
N Engl J Med; 2015 Aug; 373(6):530-9. PubMed ID: 26244306
[TBL] [Abstract][Full Text] [Related]
18. Topical microbicides--what's new?
Karim QA; Baxter C; Karim SA
J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2():S144-9. PubMed ID: 23764627
[TBL] [Abstract][Full Text] [Related]
19. Use of antiviral drugs to prevent herpesvirus transmission.
Crumpacker CS
N Engl J Med; 2004 Jan; 350(1):67-8. PubMed ID: 14702430
[No Abstract] [Full Text] [Related]
20. The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment.
Seay K; Khajoueinejad N; Zheng JH; Kiser P; Ochsenbauer C; Kappes JC; Herold B; Goldstein H
J Virol; 2015 Sep; 89(18):9559-70. PubMed ID: 26157126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
